To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene WDFY1andAP1S3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
474 supporting clones for gene WDFY1andAP1S3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA775670 brain .a 1 to 572 2 to 573   tiling clone, capped   572/572
(100 %)
0 diff
(100 %id)
AJ310568   .a 13 to 1833 1 to 1821 exact     1821/1821
(100 %)
2 diff
(99.9 %id)
DA531164 brain .a 29 to 639 2 to 612   capped   611/611
(100 %)
0 diff
(100 %id)
DA786367 brain .a 29 to 469 2 to 445   capped   444/444
(100 %)
4 diff
(99.1 %id)
BG401678 Kidney .a 52 to 742 1 to 690       690/895
(77 %)
14 diff
(98.5 %id)
NM_020830.3   .a 52 to 4658 1 to 4607 exact RefSeq,   4607/4607
(100 %)
3 diff
(100.0 %id)
DA216115 brain .a 53 to 600 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA387368 thalamus .a 53 to 625 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA476802   .a 53 to 610 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DA754993   .a 53 to 590 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DA754994   .a 53 to 471 2 to 425   capped   424/424
(100 %)
6 diff
(98.6 %id)
DA855644 placenta .a 53 to 607 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
DA859584 placenta .a 53 to 591 2 to 540   capped   539/541
(99 %)
4 diff
(99.3 %id)
DB463633 hippocampus .a 55 to 493 1 to 441       441/441
(100 %)
6 diff
(98.7 %id)
BP364649 lung .a 55 to 635 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BC065934 Skin, melanotic melanoma. .a 56 to 4657 1 to 4604 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 4604/4604
(100 %)
9 diff
(99.9 %id)
DA450698 tongue, tumor tissue .a 56 to 628 2 to 576   capped   575/575
(100 %)
4 diff
(99.4 %id)
DA479400   .a 56 to 532 2 to 478   capped   477/477
(100 %)
4 diff
(99.2 %id)
BU167040 melanotic melanoma, skin .a 58 to 827 1 to 775       775/905
(85 %)
4 diff
(99.6 %id)
BP200138 amygdala .a 59 to 640 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DB175660 kidney, tumor tissue .a 59 to 612 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
TI_57236041   .a 62 to 827 27 to 801       775/913
(84 %)
17 diff
(98.2 %id)
BQ071357 brain, neuroblastoma, cell line .a 65 to 761 1 to 705       705/1148
(61 %)
15 diff
(98.7 %id)
BI910053 leukocyte .a 66 to 827 1 to 771       771/883
(87 %)
17 diff
(98.1 %id)
BE262784 brain, neuroblastoma .a 73 to 830 18 to 774       757/914
(82 %)
14 diff
(98.5 %id)
AK022888   .a 74 to 4657 1 to 4585 exact tiling clone, available from FLJ,   4585/4585
(100 %)
10 diff
(99.8 %id)
AU128194   .a 74 to 702 2 to 633   capped   632/642
(98 %)
9 diff
(98.6 %id)
DA597277   .a 75 to 605 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
DB491494 hypothalamus .a 76 to 382 1 to 307       307/314
(97 %)
16 diff
(95.0 %id)
BG759326 B-cells, primary B-cells from tonsils (cell line) .a 77 to 827 1 to 753       753/840
(89 %)
4 diff
(99.6 %id)
DA179376 amygdala .a 78 to 627 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
AW963897   .a 80 to 382 1 to 303       303/308
(98 %)
11 diff
(96.5 %id)
AL036048 brain .a 83 to 348 1 to 266       266/266
(100 %)
2 diff
(99.3 %id)
DA239229 brain .a 84 to 647 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
CB987238 Pooled-Glandular .a 85 to 830 1 to 746       746/751
(99 %)
9 diff
(98.9 %id)
DA105327 cerebellum .a 86 to 657 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA349776 substantia nigra .a 86 to 668 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DB036535 testis .a 86 to 655 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
AB037856 brain .a 87 to 4657 1 to 4574 exact tiling clone, available from KIAA,   4574/4574
(100 %)
9 diff
(99.9 %id)
BC040525 Brain, hypothalamus .a 88 to 4657 1 to 4571 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 4571/4571
(100 %)
10 diff
(99.8 %id)
DB489837 hypothalamus .a 88 to 537 1 to 450       450/450
(100 %)
3 diff
(99.4 %id)
CF993813 Human Placenta, placenta .a 88 to 800 28 to 749       722/878
(82 %)
28 diff
(96.9 %id)
BP310477 brain .a 88 to 690 1 to 603       603/603
(100 %)
4 diff
(99.4 %id)
BP313764 mammary gland .a 88 to 670 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP320297 placenta .a 88 to 686 1 to 598       598/598
(100 %)
2 diff
(99.7 %id)
DA106387 cerebellum .a 89 to 633 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA283116 corpus callosum .a 89 to 648 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA287515 corpus callosum .a 89 to 630 2 to 546   capped   545/545
(100 %)
3 diff
(99.5 %id)
DA317790 hippocampus .a 89 to 647 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DA408201 thalamus .a 89 to 632 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA465467   .a 89 to 656 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA477740   .a 89 to 615 2 to 530   capped   529/529
(100 %)
2 diff
(99.7 %id)
DA488267 brain .a 89 to 656 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA549980   .a 89 to 677 2 to 590   capped   589/589
(100 %)
3 diff
(99.5 %id)
DA671809   .a 89 to 677 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DA881993   .a 89 to 640 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA936631 Spleen .a 89 to 677 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
DB214325 trachea .a 89 to 655 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DB225620 trachea .a 89 to 639 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
BQ924238 large cell carcinoma, lung .a 90 to 1035 1 to 949       949/951
(99 %)
17 diff
(98.3 %id)
W03471 melanocyte .a 91 to 434 1 to 345       345/348
(99 %)
2 diff
(99.5 %id)
BM552524 leiomyosarcoma, uterus .a 91 to 932 13 to 857       845/1011
(83 %)
14 diff
(98.7 %id)
DR000095 fetal brain .a 92 to 789 1 to 698       698/698
(100 %)
4 diff
(99.5 %id)
BP237201 coronary artery .a 96 to 675 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
ES312748 beard hair, skin .a 97 to 239 1 to 143       143/151
(94 %)
1 diff
(99.4 %id)
BP278826   .a 99 to 681 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DB267057 uterus .a 99 to 637 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA408424 thalamus .a 100 to 670 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
TI_1948156272   .a 102 to 731 138 to 767   fully sequenced, AAA   630/767
(82 %)
0 diff
(100 %id)
TI_1948156444   .a 102 to 731 136 to 765   fully sequenced,   630/765
(82 %)
0 diff
(100 %id)
TI_1948156618   .a 102 to 731 129 to 758   fully sequenced,   630/758
(83 %)
0 diff
(100 %id)
TI_1948156795   .a 102 to 731 132 to 761   fully sequenced,   630/761
(82 %)
0 diff
(100 %id)
DB096086 testis .a 102 to 671 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
AF411977   .a 103 to 1335 1 to 1233 exact     1233/1233
(100 %)
0 diff
(100 %id)
EL733813 mixed .a 103 to 769 1 to 663       663/663
(100 %)
5 diff
(99.3 %id)
BF334664 colon .a 110 to 529 1 to 420       420/420
(100 %)
2 diff
(99.6 %id)
CU456693 epidermis .a 120 to 634 11 to 525       515/542
(95 %)
1 diff
(99.9 %id)
BE618442 eye, retinoblastoma .a 126 to 827 1 to 704     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 704/1011
(69 %)
22 diff
(97.9 %id)
BM470844 leiomyosarcoma, uterus .a 215 to 1145 1 to 937       937/1038
(90 %)
18 diff
(98.3 %id)
W03468 melanocyte .a 232 to 414 5 to 187       183/187
(97 %)
1 diff
(99.5 %id)
DA703559   .a 381 to 877 2 to 498   capped   497/497
(100 %)
1 diff
(99.8 %id)
DA725855   .a 434 to 985 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DB274214 uterus .a 459 to 1013 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
CA398252 eye, RPE/choroid .a 497 to 1045 1 to 549     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 549/549
(100 %)
0 diff
(100 %id)
AW753430 colon .a 567 to 775 211 to 6       206/229
(89 %)
11 diff
(95.2 %id)
BQ333693 marrow .a 603 to 910 322 to 1       322/329
(97 %)
36 diff
(89.1 %id)
BF359780 marrow .a 648 to 941 301 to 8       294/301
(97 %)
0 diff
(100 %id)
BF359789 marrow .a 648 to 934 302 to 14       289/302
(95 %)
1 diff
(99.7 %id)
BE890413 melanotic melanoma, skin .a 656 to 1275 1 to 623       623/884
(70 %)
6 diff
(99.4 %id)
C02756 heart .a 662 to 981 1 to 320       320/320
(100 %)
4 diff
(98.8 %id)
TI_1948156273   .a 670 to 1334 790 to 129   fully sequenced,   662/790
(83 %)
0 diff
(100 %id)
TI_1948156445   .a 670 to 1334 790 to 126   fully sequenced,   665/790
(84 %)
1 diff
(99.9 %id)
TI_1948156619   .a 670 to 1334 789 to 126   fully sequenced,   664/789
(84 %)
1 diff
(99.9 %id)
TI_1948156796   .a 670 to 1334 789 to 126   fully sequenced,   664/789
(84 %)
0 diff
(100 %id)
BF359792 marrow .a 700 to 997 29 to 327       299/327
(91 %)
1 diff
(99.7 %id)
FN139187 breast carcinoma .a 943 to 1035 1 to 91       91/91
(100 %)
2 diff
(97.9 %id)
CD644244 Embryonic Stem cells .a 994 to 1732 8 to 745       738/839
(87 %)
5 diff
(99.5 %id)
TI_59392806   .a 1025 to 1766 87 to 839       753/900
(83 %)
15 diff
(98.4 %id)
BM014752 breast, mammary adenocarcinoma, cell line .a 1026 to 1766 1 to 752       752/899
(83 %)
15 diff
(98.4 %id)
DA723245   .a 1040 to 1614 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BU154908 melanotic melanoma, skin .a 1139 to 2013 28 to 921       892/923
(96 %)
44 diff
(95.3 %id)
BX489444   .a 1145 to 1820 1 to 675       675/675
(100 %)
5 diff
(99.3 %id)
BI113684 muscle, rhabdomyosarcoma .a 1185 to 1622 1 to 445       445/610
(72 %)
12 diff
(98.1 %id)
DA125910 cerebellum .a 1203 to 1751 2 to 550   capped   549/549
(100 %)
5 diff
(99.1 %id)
BP335373 coronary artery .a 1222 to 1803 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
BG215597   .a 1272 to 2065 1 to 793       793/793
(100 %)
15 diff
(98.2 %id)
AW505014 lymph .a 1305 to 1714 1 to 410       410/410
(100 %)
5 diff
(98.8 %id)
TI_154161441   .a 1311 to 1885 71 to 646       576/579
(99 %)
21 diff
(96.4 %id)
C18641 placenta .a 1316 to 1769 1 to 454       454/454
(100 %)
1 diff
(99.8 %id)
BF809349 colon_ins .a 1342 to 1832 490 to 1     Submitted on the opposite strand 490/490
(100 %)
11 diff
(97.8 %id)
AA375498 lung .a 1363 to 1699 1 to 340       340/340
(100 %)
6 diff
(98.3 %id)
AW963808   .a 1364 to 1880 1 to 517       517/525
(98 %)
7 diff
(98.7 %id)
CB160619 Liver .a 1369 to 1951 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA720249   .a 1448 to 2031 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
AL120964 melanoma (MeWo cell line) .a 1480 to 2010 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
BU183161 melanotic melanoma, skin .a 1500 to 2372 1 to 878       878/879
(99 %)
12 diff
(98.7 %id)
AV745722 Pituitary .a 1550 to 2170 1 to 612       612/704
(86 %)
17 diff
(97.6 %id)
AV745812 Pituitary .a 1552 to 2148 1 to 585       585/589
(99 %)
15 diff
(97.5 %id)
AV746223 Pituitary .a 1553 to 2053 1 to 500       500/564
(88 %)
2 diff
(99.7 %id)
BP289232 lung .a 1573 to 2155 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
CD518767 White Matter .a 1634 to 2493 32 to 899       868/933
(93 %)
8 diff
(99.2 %id)
CN360252 embryonic stem cells, DMSO-treated H9 cellline .a 1668 to 2334 1 to 668       668/668
(100 %)
2 diff
(99.8 %id)
W56410 melanocyte .a 1716 to 2128 1 to 419       419/425
(98 %)
11 diff
(97.5 %id)
BX115673 melanocyte .a 1717 to 2482 1 to 766   tiling clone,   766/767
(99 %)
3 diff
(99.7 %id)
BF829370 head_normal .a 1760 to 1960 1 to 194       194/203
(95 %)
10 diff
(95.1 %id)
N28280 melanocyte .a 1765 to 2290 11 to 539       529/586
(90 %)
7 diff
(98.9 %id)
N27710 melanocyte .a 1765 to 2258 12 to 509       498/509
(97 %)
0 diff
(100 %id)
AA101454 brain, neuroepithelial cells .a 1788 to 2218 1 to 432       432/432
(100 %)
2 diff
(99.6 %id)
DA536295 heart .a 1804 to 2386 2 to 584   capped   583/583
(100 %)
3 diff
(99.5 %id)
CB132033 Liver .a 1864 to 2491 1 to 628       628/628
(100 %)
1 diff
(99.9 %id)
AU127444   .a 1876 to 2494 2 to 623   capped   622/653
(95 %)
8 diff
(98.8 %id)
BE010858 breast_normal .a 1897 to 2266 11 to 380       370/380
(97 %)
0 diff
(100 %id)
BE010865 breast_normal .a 1897 to 2266 11 to 380       370/380
(97 %)
0 diff
(100 %id)
BE816098 breast_normal .a 1897 to 2291 400 to 5       396/417
(94 %)
0 diff
(100 %id)
BE926185 breast_normal .a 1897 to 2263 11 to 377       367/383
(95 %)
7 diff
(98.2 %id)
BE926190 breast_normal .a 1897 to 2266 2 to 370       369/388
(95 %)
11 diff
(97.2 %id)
BE926191 breast_normal .a 1897 to 2266 13 to 382       370/382
(96 %)
0 diff
(100 %id)
DA746858   .a 1900 to 2464 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
H96762 melanocyte .a 1914 to 2212 1 to 306       306/321
(95 %)
10 diff
(96.9 %id)
BX483745   .a 1946 to 2677 1 to 732       732/734
(99 %)
8 diff
(99.0 %id)
BU619805 Cell Line, Chondrosarcoma .a 1951 to 2688 755 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 737/737
(100 %)
3 diff
(99.6 %id)
BE963475 eye, retinoblastoma .a 1971 to 2688 728 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 713/941
(75 %)
38 diff
(96.0 %id)
DA887070   .a 1981 to 2545 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
BX505205   .a 1993 to 2593 1 to 601       601/601
(100 %)
4 diff
(99.4 %id)
BM832512 stomach .a 1996 to 2491 1 to 497       497/497
(100 %)
1 diff
(99.8 %id)
CD171698 testis .a 2061 to 2853 1 to 799       799/913
(87 %)
14 diff
(98.5 %id)
AU137102 placenta .a 2070 to 2746 2 to 680   capped   679/679
(100 %)
6 diff
(99.2 %id)
AA040478 heart .a 2071 to 2365 1 to 301   fully sequenced,   301/301
(100 %)
2 diff
(99.4 %id)
DA500012 brain .a 2072 to 2642 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
R80463 placenta .a 2079 to 2358 1 to 287   fully sequenced,   287/287
(100 %)
5 diff
(98.3 %id)
H23902 brain .a 2079 to 2306 1 to 228       228/231
(98 %)
5 diff
(97.9 %id)
CB144001 Liver .a 2086 to 2439 11 to 364       354/364
(97 %)
0 diff
(100 %id)
BM692877 eye, Retina Foveal and Macular .a 2086 to 2673 1 to 588       588/588
(100 %)
0 diff
(100 %id)
BF877855 lung_tumor .a 2112 to 2592 483 to 3     Submitted on the opposite strand 481/483
(99 %)
0 diff
(100 %id)
DA710476   .a 2118 to 2588 2 to 472   capped   471/471
(100 %)
0 diff
(100 %id)
TI_149272435   .a 2158 to 2724 123 to 689     Submitted on the opposite strand 567/1100
(51 %)
2 diff
(99.9 %id)
BU675068 lung, Primary Lung Epithelial Cells .a 2158 to 2724 53 to 619     Submitted on the opposite strand 567/635
(89 %)
2 diff
(99.7 %id)
AI858076 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 2193 to 2687 495 to 1       495/495
(100 %)
1 diff
(99.8 %id)
AW070738 pooled .a 2196 to 2688 493 to 1       493/493
(100 %)
0 diff
(100 %id)
BE817595 breast_normal .a 2201 to 2508 11 to 320       310/320
(96 %)
0 diff
(100 %id)
BP393841 pancreatic islet .a 2212 to 2688 1 to 478     Submitted on the opposite strand 478/478
(100 %)
2 diff
(99.6 %id)
BE817545 breast_normal .a 2214 to 2613 24 to 422       399/422
(94 %)
0 diff
(100 %id)
H96669 melanocyte .a 2226 to 2689 465 to 1       465/465
(100 %)
3 diff
(99.4 %id)
EH341201   .a 2264 to 2338 1 to 74       74/74
(100 %)
3 diff
(96.0 %id)
AA971266 pooled .a 2267 to 2688 422 to 1       422/422
(100 %)
4 diff
(99.1 %id)
AI298822 carcinoid, lung .a 2267 to 2687 421 to 1       421/421
(100 %)
2 diff
(99.6 %id)
BQ024658 placenta .a 2270 to 2688 437 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 419/419
(100 %)
1 diff
(99.8 %id)
BF905512 marrow .a 2274 to 2486 1 to 211       211/211
(100 %)
6 diff
(97.2 %id)
N67497 melanocyte .a 2296 to 2689 402 to 1   tiling clone,   402/404
(99 %)
12 diff
(97.1 %id)
AI432947 adenocarcinoma, Pancreas .a 2299 to 2693 395 to 1       395/395
(100 %)
1 diff
(99.8 %id)
N67494 melanocyte .a 2303 to 2689 393 to 1       393/400
(98 %)
14 diff
(96.5 %id)
N66826 melanocyte .a 2303 to 2689 390 to 1       390/448
(87 %)
4 diff
(99.2 %id)
DA847561 placenta .a 2304 to 2860 2 to 559   capped   558/558
(100 %)
4 diff
(99.3 %id)
AW015795   .a 2309 to 2688 397 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 380/380
(100 %)
1 diff
(99.8 %id)
T80113.
matches multiple genes
liver and spleen .a 2313 to 2683 389 to 7     also hits gene N4BP2L2andN4BP2L1 383/413
(92 %)
0 diff
(100 %id)
DB196945 trachea .a 2313 to 2901 2 to 591   capped   590/590
(100 %)
4 diff
(99.4 %id)
BU619277 Cell Line, Chondrosarcoma .a 2318 to 2937 635 to 15   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 621/621
(100 %)
6 diff
(99.1 %id)
AA834561 germinal center B cell .a 2325 to 2697 373 to 1       373/373
(100 %)
1 diff
(99.8 %id)
N20868 melanocyte .a 2327 to 2688 365 to 1       365/477
(76 %)
6 diff
(98.8 %id)
AA972995 pooled .a 2327 to 2688 362 to 1       362/362
(100 %)
1 diff
(99.8 %id)
R80664 placenta .a 2328 to 2674 353 to 1   fully sequenced,   353/353
(100 %)
2 diff
(99.5 %id)
AA040384 heart .a 2335 to 2689 356 to 1   fully sequenced,   356/356
(100 %)
2 diff
(99.5 %id)
BP240687 Liver .a 2341 to 2907 1 to 568       568/568
(100 %)
7 diff
(98.8 %id)
BQ023916 placenta .a 2341 to 2688 366 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 348/348
(100 %)
1 diff
(99.8 %id)
DA297242 hippocampus .a 2344 to 2891 2 to 551   capped   550/550
(100 %)
5 diff
(99.1 %id)
DA055989 cerebellum .a 2347 to 2933 2 to 589   capped   588/588
(100 %)
5 diff
(99.2 %id)
DA666057   .a 2356 to 2906 2 to 552   capped   551/551
(100 %)
4 diff
(99.3 %id)
CA391143 eye, RPE/choroid .a 2372 to 2917 1 to 549       549/549
(100 %)
4 diff
(99.3 %id)
AA295131 Pancreas .a 2377 to 2696 321 to 1     Submitted on the opposite strand 321/321
(100 %)
4 diff
(98.8 %id)
AW117799 esophagus, squamous cell carcinoma .a 2388 to 2688 302 to 1       302/302
(100 %)
3 diff
(99.1 %id)
BG166441 hypernephroma, cell line, Kidney .a 2417 to 3061 1 to 652       652/653
(99 %)
37 diff
(94.4 %id)
BX645184   .a 2456 to 2932 1 to 477       477/477
(100 %)
5 diff
(99.0 %id)
BP269524 thyroid .a 2457 to 3037 1 to 580       580/580
(100 %)
8 diff
(98.7 %id)
DA938639 Spleen .a 2460 to 3049 2 to 593   capped   592/592
(100 %)
5 diff
(99.2 %id)
DA915307   .a 2471 to 3012 2 to 544   capped   543/543
(100 %)
5 diff
(99.1 %id)
DA712914   .a 2475 to 3029 2 to 555   capped   554/554
(100 %)
5 diff
(99.1 %id)
AA443381   .a 2487 to 2726 13 to 251     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 239/251
(95 %)
0 diff
(100 %id)
BF904435 marrow .a 2494 to 2717 223 to 4     Submitted on the opposite strand 220/245
(89 %)
0 diff
(100 %id)
BE817527 breast_normal .a 2506 to 2808 322 to 20       303/322
(94 %)
0 diff
(100 %id)
AA310942   .a 2515 to 2992 1 to 476       476/476
(100 %)
6 diff
(98.8 %id)
AW953498   .a 2516 to 3226 1 to 711       711/712
(99 %)
17 diff
(97.7 %id)
DA001312   .a 2530 to 3063 2 to 536   capped   535/535
(100 %)
5 diff
(99.1 %id)
DA711951   .a 2583 to 2964 2 to 385   capped   384/393
(97 %)
8 diff
(98.0 %id)
DA750076   .a 2583 to 3150 2 to 570   capped   569/569
(100 %)
5 diff
(99.2 %id)
AU139527 placenta .a 2588 to 3323 2 to 743   capped   742/744
(99 %)
13 diff
(98.3 %id)
CN360256 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2603 to 3364 7 to 767       761/767
(99 %)
0 diff
(100 %id)
BX483230   .a 2622 to 3043 1 to 424       424/424
(100 %)
5 diff
(98.9 %id)
BX483245   .a 2622 to 3077 1 to 458       458/458
(100 %)
5 diff
(99.0 %id)
BG899525 cartilage .a 2629 to 2943 98 to 412       315/343
(91 %)
0 diff
(100 %id)
DA690226   .a 2630 to 3170 2 to 542   capped   541/541
(100 %)
4 diff
(99.3 %id)
BQ425953 melanotic melanoma, skin .a 2645 to 3548 1 to 915       915/920
(99 %)
25 diff
(97.3 %id)
DB271972 uterus .a 2662 to 3205 2 to 545   capped   544/544
(100 %)
7 diff
(98.8 %id)
DA282189 corpus callosum .a 2668 to 3235 2 to 570   capped   569/569
(100 %)
6 diff
(99.0 %id)
DA023652   .a 2688 to 3257 2 to 572   capped   571/571
(100 %)
5 diff
(99.2 %id)
BI857325 breast, mammary adenocarcinoma, cell line .a 2721 to 3453 15 to 746       732/747
(97 %)
8 diff
(99.0 %id)
TI_57187633   .a 2721 to 3453 66 to 797       732/747
(97 %)
8 diff
(99.0 %id)
AA058405 colon, tumor .a 2750 to 3146 1 to 401       401/402
(99 %)
7 diff
(98.3 %id)
DA676372   .a 2763 to 3349 2 to 589   capped   588/588
(100 %)
4 diff
(99.4 %id)
BP274061   .a 2768 to 3324 1 to 557       557/557
(100 %)
8 diff
(98.6 %id)
DB013405 esophageal, tumor tissue .a 2789 to 3356 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
CN360257 embryonic stem cells, cell lines H1, H7, andH9 .a 2800 to 3510 1 to 710       710/710
(100 %)
6 diff
(99.2 %id)
AU139260 placenta .a 2814 to 3463 2 to 653   capped   652/652
(100 %)
7 diff
(99.0 %id)
BQ923673 leiomyosarcoma, uterus .a 2822 to 3625 1 to 812       812/869
(93 %)
26 diff
(97.1 %id)
BP380220 uterus .a 2822 to 3404 1 to 582   tiling clone,   582/582
(100 %)
2 diff
(99.7 %id)
BP376088 uterus .a 2843 to 3402 1 to 560       560/560
(100 %)
10 diff
(98.3 %id)
DA595692 lung .a 2845 to 3422 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
BP276085 Kidney .a 2888 to 3381 1 to 495       495/583
(84 %)
29 diff
(95.1 %id)
GD153271   .a 2891 to 3058 1 to 170       170/172
(98 %)
5 diff
(97.1 %id)
DA682975   .a 2919 to 3451 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
BU945159 mixed (pool of 40 RNAs) .a 2985 to 3818 1 to 844       844/846
(99 %)
17 diff
(98.0 %id)
AA164429   .a 2998 to 3476 1 to 479       479/480
(99 %)
2 diff
(99.6 %id)
AA164452   .a 2998 to 3475 1 to 477       477/478
(99 %)
4 diff
(99.2 %id)
BP204159 coronary artery .a 3006 to 3587 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BP423836 small intestine .a 3015 to 3477 1 to 462     Submitted on the opposite strand 462/462
(100 %)
1 diff
(99.8 %id)
BP195768 brain .a 3029 to 3611 1 to 582       582/582
(100 %)
6 diff
(99.0 %id)
BG546134 lung .a 3032 to 3841 1 to 822       822/825
(99 %)
35 diff
(95.8 %id)
BF342164 brain, glioblastoma with EGFR amplification .a 3053 to 3721 1 to 658       658/658
(100 %)
12 diff
(98.2 %id)
BP289155 lung .a 3058 to 3534 1 to 478       478/573
(83 %)
15 diff
(97.4 %id)
CV364880 head_neck .a 3066 to 3475 1 to 420       420/514
(81 %)
39 diff
(92.5 %id)
BU941406 mixed (pool of 40 RNAs) .a 3075 to 3689 1 to 631       631/742
(85 %)
18 diff
(97.6 %id)
BP375271 uterus .a 3080 to 3647 1 to 568       568/568
(100 %)
2 diff
(99.7 %id)
BF570512 melanotic melanoma, high MDR, skin .a 3106 to 3681 1 to 601       601/603
(99 %)
57 diff
(90.6 %id)
BU182689 melanotic melanoma, skin .a 3118 to 3980 1 to 875       875/882
(99 %)
20 diff
(97.8 %id)
BM541399 leiomyosarcoma, uterus .a 3141 to 4211 1 to 1066       1066/1071
(99 %)
29 diff
(97.3 %id)
BF184483 bone marrow, from chronic myelogenous leukemia .a 3156 to 3720 1 to 567       567/625
(90 %)
10 diff
(98.4 %id)
BQ962247 leiomyosarcoma, uterus .a 3171 to 4015 24 to 874       851/877
(97 %)
10 diff
(98.9 %id)
CN360255 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3172 to 3793 8 to 629       622/629
(98 %)
0 diff
(100 %id)
BP383313 ilea mucosa .a 3173 to 3620 1 to 450       450/675
(66 %)
6 diff
(99.2 %id)
BF344759 brain, glioblastoma with EGFR amplification .a 3181 to 4016 1 to 844       844/876
(96 %)
40 diff
(95.5 %id)
CN360253 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3183 to 3839 1 to 657       657/657
(100 %)
1 diff
(99.9 %id)
BP356367   .a 3183 to 3763 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BF217651 brain, glioblastoma .a 3191 to 3712 1 to 520       520/749
(69 %)
17 diff
(97.8 %id)
BG119034 adenocarcinoma, cell line, Liver .a 3226 to 3887 1 to 665       665/927
(71 %)
5 diff
(99.5 %id)
BG777963 adenocarcinoma, Prostate .a 3288 to 4006 1 to 722       722/726
(99 %)
8 diff
(98.9 %id)
BF571067 melanotic melanoma, high MDR, skin .a 3296 to 4043 1 to 749       749/767
(97 %)
23 diff
(97.1 %id)
BF692147 melanotic melanoma, high MDR, skin .a 3355 to 3888 1 to 534       534/880
(60 %)
15 diff
(98.3 %id)
AL135641 melanoma (MeWo cell line) .a 3367 to 3842 1 to 477       477/478
(99 %)
2 diff
(99.6 %id)
FN101062 breast carcinoma .a 3370 to 3483 112 to 1     Submitted on the opposite strand 112/113
(99 %)
2 diff
(98.3 %id)
BF692684 melanotic melanoma, high MDR, skin .a 3375 to 4062 1 to 682       682/876
(77 %)
15 diff
(98.3 %id)
BF700555 brain, primitive neuroectoderm .a 3380 to 4101 1 to 708       708/876
(80 %)
15 diff
(98.3 %id)
BF976875 melanotic melanoma, high MDR, skin .a 3411 to 4021 1 to 602       602/809
(74 %)
20 diff
(97.6 %id)
FN055321 breast carcinoma .a 3420 to 3534 117 to 1     Submitted on the opposite strand 117/117
(100 %)
3 diff
(97.5 %id)
EC497489 Prostate .a 3435 to 3544 1 to 106       106/106
(100 %)
6 diff
(94.4 %id)
EC555432 Prostate .a 3436 to 3542 1 to 105       105/106
(99 %)
5 diff
(95.3 %id)
FN125720 breast carcinoma .a 3466 to 3535 1 to 69       69/70
(98 %)
2 diff
(97.2 %id)
BF573349 melanotic melanoma, high MDR, skin .a 3472 to 4085 33 to 649       617/842
(73 %)
16 diff
(98.1 %id)
BF248438 melanotic melanoma, high MDR, skin .a 3488 to 4152 1 to 656       656/791
(82 %)
17 diff
(97.9 %id)
BF979221 melanotic melanoma, high MDR, skin .a 3500 to 4222 1 to 721       721/741
(97 %)
22 diff
(97.1 %id)
BF690689 melanotic melanoma, high MDR, skin .a 3500 to 4221 1 to 729       729/925
(78 %)
31 diff
(96.7 %id)
BF691781 melanotic melanoma, high MDR, skin .a 3500 to 4230 1 to 736       736/877
(83 %)
28 diff
(96.9 %id)
BQ336291 marrow .a 3516 to 3655 142 to 3       140/142
(98 %)
0 diff
(100 %id)
DB529585 hippocampus .a 3533 to 3891 1 to 361     Submitted on the opposite strand 361/363
(99 %)
15 diff
(95.9 %id)
BE789162 large cell carcinoma, lung .a 3571 to 4315 1 to 744       744/769
(96 %)
12 diff
(98.5 %id)
BE568570 bladder, carcinoma, cell line .a 3575 to 4262 1 to 684       684/686
(99 %)
16 diff
(97.7 %id)
AA242945 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3583 to 3950 1 to 368       368/368
(100 %)
0 diff
(100 %id)
BM757302 Ascites, stomach .a 3599 to 4151 1 to 553       553/553
(100 %)
3 diff
(99.5 %id)
AA228820   .a 3645 to 3832 1 to 188       188/188
(100 %)
1 diff
(99.5 %id)
AA224866   .a 3645 to 4061 1 to 417       417/417
(100 %)
4 diff
(99.1 %id)
BP295977   .a 3661 to 4239 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
R62320 placenta .a 3692 to 4023 1 to 338       338/358
(94 %)
14 diff
(96.1 %id)
R79010 placenta .a 3692 to 3810 1 to 119       119/119
(100 %)
2 diff
(98.4 %id)
BF032667 adenocarcinoma, ovary .a 3725 to 4436 1 to 718       718/860
(83 %)
21 diff
(97.6 %id)
TI_149279929   .a 3742 to 4657 1015 to 103   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 913/1053
(86 %)
23 diff
(97.9 %id)
BU160129 melanotic melanoma, skin .a 3769 to 4585 1 to 823       823/900
(91 %)
27 diff
(97.0 %id)
BE908237 epithelioid carcinoma, Pancreas .a 3781 to 4334 1 to 554       554/554
(100 %)
1 diff
(99.9 %id)
BG577121 breast, mammary adenocarcinoma, cell line .a 3796 to 4447 16 to 670       655/1049
(62 %)
18 diff
(98.3 %id)
AA411290 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3803 to 4242 1 to 440   tiling clone, fully sequenced,   440/440
(100 %)
0 diff
(100 %id)
AV757624 bone marrow .a 3814 to 4514 71 to 758       688/760
(90 %)
32 diff
(95.8 %id)
BE897710 melanotic melanoma, skin .a 3818 to 4570 1 to 740       740/909
(81 %)
27 diff
(97.1 %id)
BF571340 melanotic melanoma, high MDR, skin .a 3876 to 4596 1 to 721       721/723
(99 %)
33 diff
(95.5 %id)
BE896614 melanotic melanoma, skin .a 3879 to 4551 1 to 673       673/673
(100 %)
6 diff
(99.2 %id)
FN163168 breast carcinoma .a 3966 to 4073 107 to 1     Submitted on the opposite strand 107/107
(100 %)
3 diff
(97.2 %id)
TI_149291853   .a 3967 to 4663 790 to 86   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 705/706
(99 %)
7 diff
(99.1 %id)
AW956189   .a 3969 to 4656 688 to 1     Submitted on the opposite strand 688/688
(100 %)
16 diff
(97.7 %id)
BQ433842 melanotic melanoma, skin .a 3977 to 4518 12 to 558       547/993
(55 %)
0 diff
(100 %id)
BG613862 embryonal carcinoma, testis .a 3981 to 4662 1 to 685       685/769
(89 %)
20 diff
(97.4 %id)
BG939784 bone marrow stroma .a 3992 to 4657 706 to 39   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 668/668
(100 %)
2 diff
(99.8 %id)
CA309438 Alveolar Macrophage, lung .a 4003 to 4657 680 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 662/662
(100 %)
9 diff
(98.7 %id)
BU682241 lung .a 4012 to 4663 676 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 658/660
(99 %)
5 diff
(99.3 %id)
AI695418 pooled .a 4014 to 4658 646 to 3       644/649
(99 %)
0 diff
(100 %id)
AA884946 pooled .a 4019 to 4217 199 to 1       199/199
(100 %)
0 diff
(100 %id)
BM969803 lung, Primary Lung Epithelial Cells .a 4019 to 4657 660 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 642/642
(100 %)
2 diff
(99.7 %id)
FN110497 breast carcinoma .a 4021 to 4130 1 to 112       112/112
(100 %)
5 diff
(95.6 %id)
BG576006 breast, mammary adenocarcinoma, cell line .a 4039 to 4658 13 to 633       621/649
(95 %)
15 diff
(97.7 %id)
AA450337   .a 4048 to 4273 1 to 226       226/226
(100 %)
0 diff
(100 %id)
BE765931 nervous_tumor .a 4049 to 4250 1 to 202       202/202
(100 %)
0 diff
(100 %id)
AU150492   .a 4055 to 4657 597 to 1       597/599
(99 %)
14 diff
(97.7 %id)
BE695223 breast .a 4058 to 4431 375 to 1       375/375
(100 %)
4 diff
(99.0 %id)
FN051729 breast carcinoma .a 4072 to 4165 1 to 91       91/99
(91 %)
6 diff
(94.0 %id)
TI_157606900   .a 4083 to 4576 576 to 83       494/910
(54 %)
0 diff
(100 %id)
DB379892 placenta .a 4098 to 4657 554 to 1       554/574
(96 %)
15 diff
(97.4 %id)
BE301038 choriocarcinoma, placenta .a 4100 to 4658 562 to 2       561/562
(99 %)
0 diff
(100 %id)
TI_149281452   .a 4102 to 4657 629 to 74   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 556/794
(70 %)
9 diff
(98.9 %id)
BM983417 lung, Primary Lung Epithelial Cells .a 4102 to 4657 574 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 556/562
(98 %)
9 diff
(98.4 %id)
AW194711 Kidney .a 4103 to 4657 558 to 1       558/558
(100 %)
6 diff
(99.0 %id)
DB370148   .a 4115 to 4657 548 to 1       548/548
(100 %)
7 diff
(98.8 %id)
AU150025   .a 4120 to 4657 536 to 1       536/548
(97 %)
15 diff
(97.3 %id)
CA398251 eye, RPE/choroid .a 4121 to 4657 563 to 25   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 539/539
(100 %)
1 diff
(99.9 %id)
AI671841 pooled germ cell tumors .a 4121 to 4658 542 to 2       541/542
(99 %)
0 diff
(100 %id)
AI651650 pooled germ cell tumors .a 4140 to 4658 527 to 6       522/527
(99 %)
0 diff
(100 %id)
BF223120 pooled germ cell tumors .a 4140 to 4658 519 to 1       519/519
(100 %)
0 diff
(100 %id)
TI_154169253   .a 4141 to 4658 632 to 107     Submitted on the opposite strand 526/616
(85 %)
0 diff
(100 %id)
AA702106 pineal gland .a 4150 to 4658 511 to 1       511/511
(100 %)
2 diff
(99.7 %id)
CB161324 Liver .a 4153 to 4605 1 to 453       453/453
(100 %)
0 diff
(100 %id)
BM765499 stomach .a 4153 to 4656 1 to 505       505/505
(100 %)
1 diff
(99.9 %id)
AW798784 uterus .a 4160 to 4412 254 to 2       253/254
(99 %)
0 diff
(100 %id)
AA164430   .a 4160 to 4658 502 to 2       501/503
(99 %)
0 diff
(100 %id)
AA837096 germinal center B cell .a 4162 to 4657 516 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 499/499
(100 %)
2 diff
(99.6 %id)
AA714776 germinal center B cell .a 4169 to 4657 505 to 15   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 491/491
(100 %)
2 diff
(99.6 %id)
N35692 melanocyte .a 4171 to 4657 494 to 1       494/498
(99 %)
12 diff
(97.6 %id)
DB379513 placenta .a 4178 to 4657 487 to 1       487/491
(99 %)
18 diff
(96.4 %id)
BE695226 breast .a 4183 to 4460 280 to 2       279/280
(99 %)
0 diff
(100 %id)
AU157026 placenta .a 4184 to 4657 472 to 1       472/474
(99 %)
4 diff
(99.2 %id)
AW194722 Kidney .a 4193 to 4657 468 to 1       468/468
(100 %)
5 diff
(99.0 %id)
AI692893 pooled .a 4195 to 4658 465 to 2       464/465
(99 %)
0 diff
(100 %id)
DB564703 hypothalamus .a 4196 to 4658 1 to 465     Submitted on the opposite strand 465/467
(99 %)
2 diff
(99.6 %id)
AA446956   .a 4196 to 4657 474 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 464/464
(100 %)
2 diff
(99.6 %id)
AW243572 pooled germ cell tumors .a 4196 to 4658 463 to 1       463/463
(100 %)
0 diff
(100 %id)
BU754066 placenta .a 4201 to 4657 475 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 457/461
(99 %)
0 diff
(100 %id)
TI_149283412   .a 4207 to 4659 534 to 80   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 455/708
(64 %)
2 diff
(99.8 %id)
BE093856 breast .a 4208 to 4538 1 to 331       331/344
(96 %)
6 diff
(98.3 %id)
AI570864 adenocarcinoma, Pancreas .a 4213 to 4658 449 to 1       449/449
(100 %)
1 diff
(99.8 %id)
AI568025 adenocarcinoma, Pancreas .a 4213 to 4657 448 to 1       448/448
(100 %)
5 diff
(98.9 %id)
AA249620   .a 4217 to 4564 347 to 1     Submitted on the opposite strand 347/350
(99 %)
5 diff
(98.6 %id)
BM984062 lung, Primary Lung Epithelial Cells .a 4220 to 4659 458 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 442/442
(100 %)
2 diff
(99.6 %id)
AA406307 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4221 to 4661 441 to 1   tiling clone, fully sequenced,   441/441
(100 %)
0 diff
(100 %id)
AA058353 colon, tumor .a 4228 to 4657 433 to 1       433/435
(99 %)
2 diff
(99.6 %id)
BE093985 breast .a 4231 to 4615 400 to 19     Submitted on the opposite strand 382/414
(92 %)
0 diff
(100 %id)
AA491613 Ewing's sarcoma .a 4231 to 4563 1 to 333       333/333
(100 %)
3 diff
(99.1 %id)
BF082764 breast .a 4233 to 4602 370 to 2       369/374
(98 %)
0 diff
(100 %id)
BF063958 colon, colon tumor, RER+ .a 4238 to 4657 438 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 423/423
(100 %)
1 diff
(99.8 %id)
AI470920 Kidney .a 4240 to 4657 430 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 420/420
(100 %)
1 diff
(99.8 %id)
AA977147 pooled germ cell tumors .a 4241 to 4658 421 to 2       420/421
(99 %)
0 diff
(100 %id)
AA101378 brain, neuroepithelial cells .a 4256 to 4657 404 to 1       404/406
(99 %)
1 diff
(99.8 %id)
CF139100 CNCAP(3)T-225 cell line, Prostate .a 4262 to 4658 434 to 35     Submitted on the opposite strand 400/434
(92 %)
0 diff
(100 %id)
AA814324 germinal center B cell .a 4263 to 4658 402 to 5       398/402
(99 %)
0 diff
(100 %id)
AA773065 lung, lung carcinoma .a 4271 to 4658 391 to 2       390/391
(99 %)
0 diff
(100 %id)
AI252765 pooled .a 4277 to 4656 382 to 1       382/382
(100 %)
3 diff
(99.3 %id)
FN116511 breast carcinoma .a 4281 to 4378 99 to 1     Submitted on the opposite strand 99/99
(100 %)
3 diff
(97.0 %id)
AA242810 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4294 to 4658 374 to 8       367/374
(98 %)
0 diff
(100 %id)
AA728751 pooled germ cell tumors .a 4294 to 4657 367 to 1       367/367
(100 %)
1 diff
(99.8 %id)
AW085955 ovary, papillary serous carcinoma .a 4298 to 4657 385 to 26   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 360/360
(100 %)
4 diff
(98.9 %id)
AA224865   .a 4314 to 4658 356 to 10       347/356
(97 %)
0 diff
(100 %id)
CR743882 brain, substantia nigra .a 4317 to 4657 358 to 15   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 344/354
(97 %)
1 diff
(99.8 %id)
AA164453   .a 4321 to 4658 341 to 2       340/344
(98 %)
0 diff
(100 %id)
AW593620 hepatic adenoma, Liver .a 4325 to 4658 342 to 7       336/350
(96 %)
0 diff
(100 %id)
AA211093   .a 4331 to 4658 332 to 1       332/332
(100 %)
3 diff
(99.1 %id)
AA837137 germinal center B cell .a 4336 to 4656 332 to 10       323/332
(97 %)
0 diff
(100 %id)
BE463453 Kidney .a 4350 to 4657 309 to 1       309/309
(100 %)
1 diff
(99.7 %id)
FN158283 breast carcinoma .a 4356 to 4473 122 to 1     Submitted on the opposite strand 122/122
(100 %)
4 diff
(96.8 %id)
FN111795 breast carcinoma .a 4359 to 4420 62 to 1     Submitted on the opposite strand 62/63
(98 %)
2 diff
(96.9 %id)
FN053002 breast carcinoma .a 4373 to 4493 122 to 1     Submitted on the opposite strand 122/123
(99 %)
1 diff
(99.2 %id)
AA450338   .a 4375 to 4658 290 to 7       284/290
(97 %)
0 diff
(100 %id)
BG939793 bone marrow stroma .a 4380 to 4657 315 to 36   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 280/280
(100 %)
8 diff
(97.2 %id)
BI493920 cochlea, ear .a 4382 to 4657 299 to 21   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 279/286
(97 %)
1 diff
(99.7 %id)
AA375065 lung .a 4390 to 4658 278 to 9     Submitted on the opposite strand 270/278
(97 %)
0 diff
(100 %id)
BF589876 Kidney .a 4409 to 4658 252 to 1       252/252
(100 %)
1 diff
(99.7 %id)
DB562005 hypothalamus .a 4417 to 4658 1 to 246     Submitted on the opposite strand 246/250
(98 %)
13 diff
(94.8 %id)
AA830562 germinal center B cell .a 4444 to 4657 230 to 15   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 216/216
(100 %)
1 diff
(99.6 %id)
BU674485 lung, Primary Lung Epithelial Cells .a 4477 to 4657 201 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 183/242
(75 %)
2 diff
(99.2 %id)
AI474925 Kidney .a 4478 to 4657 182 to 1       182/182
(100 %)
1 diff
(99.5 %id)
CN360254 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1 to 720 6 to 725 exact tiling clone,   725/725
(100 %)
5 diff
(99.4 %id)
CB995006 placenta, pre-eclamptic placenta .c 1 to 724 28 to 759 F101V P164L     732/791
(92 %)
20 diff
(97.5 %id)
CB961849 placenta, pre-eclamptic placenta .c 1 to 747 28 to 777 P164L tiling clone,   750/808
(92 %)
12 diff
(98.6 %id)
DB223965 trachea .c 2 to 565 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA887854   .c 63 to 565 2 to 506   capped   505/505
(100 %)
4 diff
(99.3 %id)
BU157724 melanotic melanoma, cell line, skin .c 86 to 812 1 to 733   tiling clone,   733/843
(86 %)
8 diff
(99.1 %id)
DB559585 hypothalamus .c 397 to 802 1 to 403     Submitted on the opposite strand 403/403
(100 %)
16 diff
(96.1 %id)
F13689   .c 542 to 812 272 to 11   tiling clone, AAA   262/295
(88 %)
13 diff
(95.6 %id)
BG386072 adenocarcinoma cell line, colon .d 1 to 538 1 to 536   tiling clone,   536/536
(100 %)
3 diff
(99.5 %id)
AF393369   .d 86 to 584 1 to 499   tiling clone,   499/499
(100 %)
0 diff
(100 %id)
DN994632 brain, whole brain .e 1 to 552 33 to 584 exact tiling clone,   552/584
(94 %)
0 diff
(100 %id)
BG177582 lymph, lymphoma, cell line .f 1 to 718 1 to 720   tiling clone,   720/983
(73 %)
9 diff
(99.1 %id)
BF700161 brain, primitive neuroectoderm .f 132 to 794 1 to 664 G43V H44T R45G T46Q S47A ... AAA   663/671
(98 %)
29 diff
(95.7 %id)
BC009606 Brain, primitive neuroectodermal .f 133 to 1906 1 to 1771   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1771/1771
(100 %)
12 diff
(99.4 %id)
DA545792   .f 136 to 704 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA650125   .f 136 to 683 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA654558   .f 138 to 704 2 to 569   capped   568/568
(100 %)
5 diff
(99.2 %id)
CB998243 placenta, pre-eclamptic placenta .f 154 to 718 28 to 593       564/830
(67 %)
11 diff
(98.7 %id)
CB998235 placenta, pre-eclamptic placenta .f 154 to 656 28 to 533       506/918
(55 %)
8 diff
(99.2 %id)
CB113572 Liver .f 154 to 653 1 to 500       500/500
(100 %)
0 diff
(100 %id)
DC368966   .f 154 to 719 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
DA370836 thalamus .f 155 to 713 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA547537   .f 155 to 703 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
TI_1948098543   .f 279 to 753 119 to 592       475/496
(95 %)
6 diff
(98.8 %id)
TI_1948098678   .f 279 to 785 127 to 632       506/569
(88 %)
7 diff
(98.8 %id)
CV028080 mixed .f 288 to 785 1 to 500       500/646
(77 %)
4 diff
(99.4 %id)
TI_1948098818   .f 288 to 784 136 to 631       494/1289
(38 %)
17 diff
(98.7 %id)
DA472212   .f 291 to 656 155 to 523   capped   369/522
(70 %)
2 diff
(99.7 %id)
AW044128 pooled .f 960 to 1208 250 to 2       249/250
(99 %)
0 diff
(100 %id)
AA807521 germinal center B cell .f 1117 to 1459 345 to 3   tiling clone,   343/345
(99 %)
0 diff
(100 %id)
NM_001039569.1   .g 1 to 4005 1 to 4005 exact RefSeq,   4005/4005
(100 %)
2 diff
(100.0 %id)
BG166479 hypernephroma, cell line, Kidney .g 18 to 626 1 to 608 F49L V50L D51T W52G K53R ... tiling clone,   608/608
(100 %)
1 diff
(99.9 %id)
BU958935 mixed (pool of 40 RNAs) .g 18 to 775 1 to 761 exact     761/766
(99 %)
14 diff
(98.2 %id)
BM543339 embryonal carcinoma, cell line, testis .g 19 to 1075 1 to 1058 exact tiling clone,   1058/1065
(99 %)
31 diff
(97.1 %id)
AK299026   .g 21 to 850 1 to 830 E54G     830/830
(100 %)
1 diff
(99.9 %id)
BF697657 brain, primitive neuroectoderm .g 21 to 720 1 to 693 R45K T46D S47K S48Q D51L ...     693/876
(79 %)
33 diff
(96.3 %id)
CB994892 placenta, pre-eclamptic placenta .g 21 to 753 28 to 766 exact     739/801
(92 %)
8 diff
(99.1 %id)
CT000939 T-Lymphocytes .g 21 to 793 1 to 773 exact     773/775
(99 %)
1 diff
(99.9 %id)
DA376029 thalamus .g 22 to 593 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA606463   .g 22 to 588 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA710710   .g 38 to 592 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA718521   .g 38 to 597 2 to 564   capped   563/563
(100 %)
4 diff
(99.3 %id)
AL702835 human skeletal muscle .g 48 to 692 1 to 645 exact     645/645
(100 %)
3 diff
(99.6 %id)
DN997103 breast cancer, Mammary gland (cancer tissue) .g 55 to 660 9 to 614 exact     606/614
(98 %)
0 diff
(100 %id)
BQ887960 eye, normal pigmented retinal epithelium .g 86 to 973 1 to 891 exact     891/894
(99 %)
24 diff
(97.4 %id)
BI257794 cervical carcinoma cell line, cervix .g 97 to 804 1 to 718 E34A I35H V36C Q37S I38D ...     718/1253
(57 %)
17 diff
(98.7 %id)
BF974210 B-cells, primary B-cells from tonsils (cell line) .g 238 to 935 1 to 693       693/693
(100 %)
11 diff
(98.5 %id)
BG340480 B-cells, primary B-cells from tonsils (cell line) .g 238 to 832 1 to 594       594/594
(100 %)
2 diff
(99.7 %id)
BG109779 Bone, osteosarcoma, cell line .g 404 to 1056 1 to 653   tiling clone,   653/653
(100 %)
0 diff
(100 %id)
CF529011 placenta .g 460 to 800 358 to 18   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 341/341
(100 %)
1 diff
(99.8 %id)
AI826972 normal prostate, Prostate .g 545 to 800 256 to 1       256/256
(100 %)
5 diff
(98.1 %id)
BF447259 Prostate .g 545 to 800 256 to 1       256/256
(100 %)
0 diff
(100 %id)
AL710555 human skeletal muscle .h 1 to 309 1 to 309   tiling clone,   309/309
(100 %)
1 diff
(99.7 %id)
BQ278378 mixed (pool of 40 RNAs) .h 264 to 910 1 to 651   tiling clone,   651/911
(71 %)
18 diff
(98.1 %id)
BG958381 colon .h 415 to 986 7 to 580       574/580
(98 %)
6 diff
(99.0 %id)
BG958519 colon .h 427 to 1007 1 to 583   tiling clone,   580/583
(99 %)
13 diff
(97.8 %id)
FN136493 breast carcinoma .h 574 to 651 1 to 80       80/80
(100 %)
3 diff
(96.3 %id)
BG958512 colon .h 727 to 1320 617 to 21   tiling clone,   595/617
(96 %)
0 diff
(100 %id)
BC021898 Lymph, lymphoma .i 1 to 2309 1 to 2309 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 2309/2309
(100 %)
3 diff
(99.9 %id)
BF797443 lymph, lymphoma, cell line .i 2 to 757 1 to 749       749/1093
(68 %)
30 diff
(97.3 %id)
CV023840 mixed .i 99 to 420 1 to 324       324/485
(66 %)
6 diff
(98.8 %id)
AA828379 germinal center B cell .i 654 to 1127 484 to 11   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 474/474
(100 %)
2 diff
(99.6 %id)
BE544126 cervical carcinoma cell line, cervix .i 707 to 1318 1 to 612       612/612
(100 %)
6 diff
(99.1 %id)
AA721432 germinal center B cell .i 800 to 1127 338 to 11   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 328/328
(100 %)
0 diff
(100 %id)
CN360948 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 1072 to 1722 1 to 650       650/650
(100 %)
1 diff
(99.9 %id)
AA588353 colon, colon tumor RER+ .i 1606 to 1871 268 to 2   tiling clone,   267/268
(99 %)
0 diff
(100 %id)
CV815369 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .i 2293 to 3022 1 to 730   tiling clone,   730/730
(100 %)
5 diff
(99.4 %id)
AW994219 breast_normal .i 2296 to 2876 595 to 14     Submitted on the opposite strand 582/595
(97 %)
0 diff
(100 %id)
AW853781 colon .i 2305 to 2733 432 to 3       430/490
(87 %)
0 diff
(100 %id)
CX164455 human embryonic stem cells differentiated toan early endodermal cell type .i 2678 to 3179 1 to 503   tiling clone,   503/503
(100 %)
8 diff
(98.5 %id)
CA427358 Cell Line, Chondrosarcoma .i 2819 to 3533 1 to 715   tiling clone, Submitted on the opposite strand 715/715
(100 %)
22 diff
(97.0 %id)
BM758517 stomach .i 3263 to 3620 1 to 358       358/359
(99 %)
17 diff
(95.3 %id)
BM740525 stomach .i 3288 to 3815 1 to 526   tiling clone,   526/526
(100 %)
11 diff
(98.0 %id)
DW445615 Liver .i 3401 to 3604 17 to 220       204/220
(92 %)
6 diff
(97.3 %id)
AI474433 Prostate .i 3725 to 3986 263 to 1       263/277
(94 %)
2 diff
(99.3 %id)
AA595150 breast .i 3746 to 3979 235 to 1   tiling clone,   235/235
(100 %)
2 diff
(99.2 %id)
BE856458 Prostate .i 3746 to 3985 244 to 4       241/244
(98 %)
0 diff
(100 %id)
BE221540 malignant melanoma, metastatic to lymphnode, skin .i 3751 to 3982 243 to 13       231/243
(95 %)
0 diff
(100 %id)
AI972826 Prostate .i 3758 to 3986 230 to 1       230/230
(100 %)
2 diff
(99.2 %id)
CR747517 germinal center B cell .i 3929 to 4415 1 to 485   tiling clone,   485/485
(100 %)
2 diff
(99.6 %id)
CR748798 germinal center B cell .i 3929 to 4391 1 to 461       461/461
(100 %)
2 diff
(99.6 %id)
BI016775 lung_tumor .i 3990 to 4259 299 to 30       270/299
(90 %)
0 diff
(100 %id)
BI016772 lung_tumor .i 3995 to 4259 293 to 29   tiling clone,   265/293
(90 %)
0 diff
(100 %id)
BM045047 carcinoma, cell line, Prostate .i 4106 to 4742 1 to 652       652/690
(94 %)
32 diff
(95.4 %id)
BM549044 astrocytoma grade IV, cell line, brain .i 4108 to 5027 1 to 939   tiling clone,   939/1147
(81 %)
39 diff
(96.6 %id)
BM909230 astrocytoma grade IV, cell line, brain .i 4109 to 4687 1 to 587       587/1291
(45 %)
66 diff
(94.9 %id)
BM910934 astrocytoma grade IV, cell line, brain .i 4109 to 5064 1 to 968   tiling clone,   968/1073
(90 %)
47 diff
(95.7 %id)
BQ939686 eye, normal pigmented retinal epithelium .i 4116 to 4995 18 to 903   tiling clone,   886/960
(92 %)
16 diff
(98.4 %id)
AK025338 colon .j 1 to 2177 6 to 2182 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (24/26 A in genome downstream of last aligned base) 2182/2182
(100 %)
5 diff
(99.8 %id)
BU949997 Pancreas, Purified pancreatic islet .k 1 to 504 1 to 504 exact tiling clone, to resequence,   504/504
(100 %)
0 diff
(100 %id)
BU949708 Pancreas, Purified pancreatic islet .k 1430 to 1799 370 to 1   tiling clone, to resequence,   370/370
(100 %)
2 diff
(99.5 %id)
DA505246 brain .l 1 to 550 2 to 551 exact tiling clone, capped   550/550
(100 %)
1 diff
(99.9 %id)
BF374005 stomach_normal .l 157 to 430 44 to 320       277/320
(86 %)
0 diff
(100 %id)
DA116614 cerebellum .m 1 to 588 2 to 595   tiling clone, capped   594/594
(100 %)
2 diff
(99.7 %id)
BU656262 blood .n-u 1 to 386 1 to 386   tiling clone,   386/386
(100 %)
4 diff
(99.0 %id)
AA354146   .n-u 177 to 523 1 to 348   tiling clone,   348/351
(99 %)
4 diff
(98.9 %id)
CB054985 brain, glioblastoma (pooled) .n-u 241 to 906 10 to 674 exact tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 665/674
(98 %)
0 diff
(100 %id)
CB054984 brain, glioblastoma (pooled) .n-u 279 to 907 653 to 25 exact fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 629/629
(100 %)
3 diff
(99.6 %id)
AI184230 placenta .n-u 468 to 907 440 to 1 exact tiling clone,   440/440
(100 %)
1 diff
(99.8 %id)
FN065362 breast carcinoma .n-u 524 to 637 114 to 1     Submitted on the opposite strand 114/114
(100 %)
0 diff
(100 %id)
AA643525 colon, colon tumor RER+ .n-u 566 to 834 270 to 2       269/270
(99 %)
0 diff
(100 %id)
BM786152 stomach .o 1 to 607 1 to 607 exact tiling clone,   607/607
(100 %)
0 diff
(100 %id)
AI819417 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .o 238 to 676 451 to 12   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 440/440
(100 %)
2 diff
(99.6 %id)
BG194384   .o 273 to 681 1 to 409   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 409/409
(100 %)
6 diff
(98.6 %id)
DA042568 bladder .p 1 to 561 2 to 563 exact tiling clone, capped   562/562
(100 %)
3 diff
(99.5 %id)
BU660191 blood .q-u 1 to 507 1 to 505 N23K K24I tiling clone,   505/505
(100 %)
6 diff
(98.9 %id)
AW753869 colon .r 1 to 361 2 to 362 R11G P21T L26I S31G tiling clone,   361/370
(97 %)
8 diff
(97.9 %id)
AW847542 colon .s-u 1 to 285 1 to 288 exact tiling clone,   288/288
(100 %)
6 diff
(98.0 %id)
DA957502 Spleen .t-u 1 to 253 2 to 254 exact tiling clone, capped   253/259
(97 %)
1 diff
(99.7 %id)
AK023415 ovary, tumor tissue Gene WDFY1andAP1S3, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
BG958432 colon Gene WDFY1andAP1S3, variant not shown         This clone was ignored    
CR741611   Gene WDFY1andAP1S3, variant not shown         This clone was ignored    
AV686918 hepatocellular carcinoma Gene WDFY1andAP1S3, variant not shown         Suspected internal deletion, this clone was ignored    
DB493634 hypothalamus Gene WDFY1andAP1S3, variant not shown         Suspected internal deletion, this clone was ignored    
DA558531   Gene WDFY1andAP1S3, variant not shown       capped Suspected internal deletion, this clone was ignored    
AW003282 pooled germ cell tumors Gene WDFY1andAP1S3, variant not shown         Suspected internal deletion, this clone was ignored    
AW451560   Gene WDFY1andAP1S3, variant not shown         This clone was ignored    
BU165869 melanotic melanoma, skin Gene WDFY1andAP1S3, variant not shown         This clone was ignored    
AU155491 ovary, tumor tissue Gene WDFY1andAP1S3, variant not shown         Suspected internal deletion, this clone was ignored    
AU134546 ovary, tumor tissue Gene WDFY1andAP1S3, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB377939 placenta Gene WDFY1andAP1S3, variant not shown         Suspected internal deletion, this clone was ignored    
DA832004 placenta Gene WDFY1andAP1S3, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n-u, .o, .p, .q-u, .r, .s-u, .t-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C